نتائج البحث 441-450 من 23953 لعملية البحث عن B cell lymphomas
The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies including large ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study of the Gene Make-up of Heart ...
Jacksonville, Fla. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies ...
CAR-T cell therapy, B-cell lymphoma, Lymphoma, Diffuse large b-cell lymphoma, Non-Hodgkin lymphoma, T-cell lymphoma, Cu...taneous t-cell lymphoma, Small ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Bone marrow transplant, CAR-T cell therapy, Myelodysplastic syndromes, Leukemia, Lymphoma, B-cell lymphoma, Follicular ...lymphoma. إظهار المزيد من مجالات ...
... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial ...
Chronic lymphocytic leukemia, Acute myelogenous leukemia, B-cell lymphoma, Burkitt lymphoma, T-cell lymphoma, Follicular lymphoma. إظهار المزيد من مجالات ...
... B cell lymphoma (DLBCL) subjects who failed at ... cells in hopes of increasing immune response and protecting against breast cancer. ... Onvansertib is a drug that ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.